NCT07755436
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
- Locations
-
- NEXT Oncology Irving, Texas, United States
- NEXT Oncology Fairfax, Virginia, United States
Clinical trial condition
Platinum-resistant Ovarian Cancer (PROC)
Explore clinical trials studying Platinum-resistant Ovarian Cancer (PROC). Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Platinum-resistant Ovarian Cancer (PROC) trial results
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
- Conditions
- Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
- Locations
-
- USOR HonorHealth Phoenix, Arizona, United States
- USOR Arizona Oncology Associates Tucson, Arizona, United States
- University of California Los Angeles Medical Center Los Angeles, California, United States
- University of California, San Diego; Moores Cancer Center San Diego, California, United States
NCT07075250
- Conditions
- Platinum-resistant Ovarian Cancer (PROC)
- Locations
-
Not specified
Not yet recruiting
Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
NCT06600841
- Conditions
- Immunotherapy, Platinum-resistant Ovarian Cancer (PROC)
- Locations
-
- Fujian Cancer Hospital Fuzhou, Fujian, China
Active, not recruiting
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
NCT06334432
- Conditions
- Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- Karmanos Cancer Center Detroit, Michigan, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Carolina BioOncology Institute Huntersville, North Carolina, United States